← Back to Search

Behavioural Intervention

Vestibulo-Ocular Reflex Therapy for Mal de Debarquement Syndrome

N/A
Waitlist Available
Led By Sergei Yakushin, PhD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 month follow up
Awards & highlights

Study Summary

This trial aims to find a way to stop the symptoms of MdDS by eliminating the trigger and minimizing symptoms.

Eligible Conditions
  • Mal de Debarquement Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 6 month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Subjective Symptoms Self-report of Overall Severity
Secondary outcome measures
Dizziness Handicap Inventory (DHI) Questionnaire
VOR Direct Pathway Gain
VOR Indirect Pathway Coupling Gain
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Vestibulo-ocular reflex (VOR)Experimental Treatment1 Intervention
Treatment by re-adaptation of the vestibulo-ocular reflex (VOR) for participants with motion triggered MdDS
Group II: Habituation of velocity storageExperimental Treatment1 Intervention
Participants with motion triggered MdDS
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
re-adaptation of the vestibulo-ocular reflex
2020
N/A
~50
Habituation of velocity storage of the vestibulo-ocular reflex
2020
N/A
~50

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
858 Previous Clinical Trials
524,239 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
328 Previous Clinical Trials
178,258 Total Patients Enrolled
Sergei Yakushin, PhDPrincipal Investigator - Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
1 Previous Clinical Trials
200 Total Patients Enrolled

Media Library

Habituation of velocity storage of the vestibulo-ocular reflex (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04213079 — N/A
Mal de Debarquement Syndrome Research Study Groups: Vestibulo-ocular reflex (VOR), Habituation of velocity storage
Mal de Debarquement Syndrome Clinical Trial 2023: Habituation of velocity storage of the vestibulo-ocular reflex Highlights & Side Effects. Trial Name: NCT04213079 — N/A
Habituation of velocity storage of the vestibulo-ocular reflex (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04213079 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Frontiers in NeurologyJournal
Treatment of the Mal De Debarquement Syndrome: A 1-year Follow-up
Dai, Mingjia, Bernard Cohen, Catherine Cho, Susan Shin, and Sergei B. Yakushin. 2017. “Treatment of the Mal De Debarquement Syndrome: A 1-year Follow-up”. Frontiers in Neurology. Frontiers Media SA. doi:10.3389/fneur.2017.00175.
clinicaltrials.govStudy
Treatments of Mal de Debarquement Syndrome (MdDS) by Habituation of Velocity Storage
Sergei Yakushin 2020. "Treatments of Mal de Debarquement Syndrome (MdDS) by Habituation of Velocity Storage". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04213079.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top